A critical evaluation of the status of HPV vaccination in São Paulo State, Brazil.

IF 2.2 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Clinics Pub Date : 2024-11-06 eCollection Date: 2024-01-01 DOI:10.1016/j.clinsp.2024.100526

Toni Ricardo Martins, Steven S Witkin, Andressa da Silva Ferreira, Juliana Yukari K Viscondi, Maryana Stephany Ferreira Branquinho, Lise Cury, Lucy Santos Vilas Boas, Adhemar Longatto-Filho, Maria Cássia Mendes-Corrêa

{"title":"A critical evaluation of the status of HPV vaccination in São Paulo State, Brazil.","authors":"Toni Ricardo Martins, Steven S Witkin, Andressa da Silva Ferreira, Juliana Yukari K Viscondi, Maryana Stephany Ferreira Branquinho, Lise Cury, Lucy Santos Vilas Boas, Adhemar Longatto-Filho, Maria Cássia Mendes-Corrêa","doi":"10.1016/j.clinsp.2024.100526","DOIUrl":null,"url":null,"abstract":"Cervical cancer, whose well-recognized etiological agent is the Human Papillomavirus (HPV), is responsible for approximately 300,000 deaths worldwide, 80% of cases occurring in developing countries. In Brazil, 17,010 cases were expected, with 2,550 cases in São Paulo State, in 2023. The Papanicolaou test is the diagnostic method for the detection of precancerous lesions of the cervix, and HPV vaccination is now available for prevention.Materials and methods: This is a descriptive and exploratory, retrospective investigation, carried out through analysis of data obtained from Brazilian Information Technology (DATASUS) of the Brazilian Federal Government: Cancer Information System (SISCAN), Brazilian National Immunization Program (PNI) and Mortality Information System (SIM). Electronic Library and data made available by the Government of the State of São Paulo.Results: The number of women in São Paulo State who underwent cytological examinations and histological tests for cervical cancer decreased between the Years 2013 and 2022.Conclusion: The continuous increase in cervical cancer over the study period was probably due to the lack of adherence to the primary and secondary prevention opportunities offered by the Public Health Authorities.","PeriodicalId":10472,"journal":{"name":"Clinics","volume":"79 ","pages":"100526"},"PeriodicalIF":2.2000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570814/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.clinsp.2024.100526","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Cervical cancer, whose well-recognized etiological agent is the Human Papillomavirus (HPV), is responsible for approximately 300,000 deaths worldwide, 80% of cases occurring in developing countries. In Brazil, 17,010 cases were expected, with 2,550 cases in São Paulo State, in 2023. The Papanicolaou test is the diagnostic method for the detection of precancerous lesions of the cervix, and HPV vaccination is now available for prevention.

Materials and methods: This is a descriptive and exploratory, retrospective investigation, carried out through analysis of data obtained from Brazilian Information Technology (DATASUS) of the Brazilian Federal Government: Cancer Information System (SISCAN), Brazilian National Immunization Program (PNI) and Mortality Information System (SIM). Electronic Library and data made available by the Government of the State of São Paulo.

Results: The number of women in São Paulo State who underwent cytological examinations and histological tests for cervical cancer decreased between the Years 2013 and 2022.

Conclusion: The continuous increase in cervical cancer over the study period was probably due to the lack of adherence to the primary and secondary prevention opportunities offered by the Public Health Authorities.

查看原文本刊更多论文

对巴西圣保罗州人乳头瘤病毒疫苗接种情况的重要评估。

宫颈癌的病原体是人类乳头瘤病毒（HPV），已被公认为是导致全球约 30 万人死亡的罪魁祸首，其中 80% 的病例发生在发展中国家。预计到 2023 年，巴西将出现 17 010 例病例，其中圣保罗州将出现 2 550 例。巴氏涂片是检测宫颈癌前病变的诊断方法，目前可通过接种人乳头瘤病毒疫苗进行预防：这是一项描述性和探索性的回顾性调查，通过分析从巴西联邦政府的巴西信息技术（DATASUS）获得的数据进行：癌症信息系统（SISCAN）、巴西国家免疫计划（PNI）和死亡率信息系统（SIM）。圣保罗州政府提供的电子图书馆和数据：结果：2013年至2022年期间，圣保罗州接受宫颈癌细胞学检查和组织学检测的妇女人数有所下降：在研究期间，宫颈癌发病率持续上升，这可能是由于缺乏对公共卫生部门提供的一级和二级预防机会的坚持。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinics 医学-医学：内科

CiteScore

4.10

自引率

3.70%

发文量

129

审稿时长

52 days

期刊介绍： CLINICS is an electronic journal that publishes peer-reviewed articles in continuous flow, of interest to clinicians and researchers in the medical sciences. CLINICS complies with the policies of funding agencies which request or require deposition of the published articles that they fund into publicly available databases. CLINICS supports the position of the International Committee of Medical Journal Editors (ICMJE) on trial registration.